Synthesis and biological activity of DL-3-(5-benzimidazolyl)-2-methylalanine.
D000409:Alanine / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000494:pharmacology; D000818:Animals; D001562:Benzimidazoles / Q000138:chemical synthesis* / Q000494:pharmacology; D001923:Brain Chemistry / Q000187:drug effects; D003864:Depression, Chemical; D004298:Dopamine / Q000032:analysis; D004837:Epinephrine / Q000032:analysis; D007700:Kinetics; D008297:Male; D009206:Myocardium / Q000032:analysis; D009928:Organ Specificity; D011485:Protein Binding / Q000187:drug effects; D051381:Rats; D012701:Serotonin / Q000032:analysis; D013997:Time Factors; D014443:Tyrosine / Q000037:antagonists & inhibitors / Q000378:metabolism; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors / Q000378:metabolism
D001562:Benzimidazoles; C006700:3-(5-benzimidazolyl)-2-methylalanine; D012701:Serotonin; D014443:Tyrosine; D014446:Tyrosine 3-Monooxygenase; D000409:Alanine; D004298:Dopamine; D004837:Epinephrine